VIM and hepatocellular carcinoma: Overall, we revealed that the tumor-suppressive function of VIM-AS1 was regulated by cg02746869, which modulated EPHA3 mRNA stability, suggesting a basis for HCC progression and the development of potential biomarkers and therapeutic targets for HCC.